Master of Science (MSc)

Pharmaceutical and Molecular Biotechnology

Are you interested in the development and production of modern medicines? Innovative RNA, protein and cell-based therapies? Bioinformatics and AI-supported drug development? Then you've come to the right place!
Pharmaceutical and Molecular Biotechnology (PMB) combines pharmaceutical research with modern therapeutic approaches and teaches how bioinformatics and AI can be used effectively in these processes. The programme specifically prepares you for demanding positions in the biopharmaceutical industry, research and development. The newly aligned programme will replace the previous Master's programme in Pharmaceutical Biotechnology (PBT).

We are pleased to announce that, following formal approval by the Ministry of Science, Research and Arts Baden-Württemberg, we will be offering the new degree programme in Pharmaceutical and Molecular Biotechnology at Ulm University from the 2026/27 winter semester. Applications can be submitted from 1 April to 15 May 2026 and from 1 June to 15 July 2026.

More about the course

The new Pharmaceutical and Molecular Biotechnology (PMB) degree programme focuses on protein, RNA and (stem) cell-based therapies, which are increasingly shaping the development of new drugs.
This is complemented by teaching bioinformatic approaches – including the targeted use of artificial intelligence – for analysing complex biological data and developing and manufacturing active substances.
The result is a programme at the interface of molecular biology, pharmacy and data-driven biotechnology.

Academic Degree

Master of Science (MSc)

Type of Study